MétaCan
Menu
Retour à la cohorte
Enregistrement W4310438946 · doi:10.3310/cwwh0622

Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT

2022· article· en· W4310438946 sur OpenAlexfundno aff
Lucy C. Chappell, Peter Brocklehurst, Marcus Green, Pollyanna Hardy, Rachael Hunter, Alice Beardmore‐Gray, Ursula Bowler, Anna Brockbank, Virginia Chiocchia, Alice Cox, Kate Duhig, Jessica Fleminger, Carolyn Gill, Melanie Greenland, Eleanor Hendy, Ann Kennedy, Paul Leeson, Louise Linsell, Fergus P. McCarthy, Jamie M. O’Driscoll, Anna Placzek, Lucilla Poston, Stephen C. Robson, Pauline Rushby, Jane Sandall, Laura Scholtz, Paul T. Seed, Jenie Sparkes, Kayleigh Stanbury, Sue Tohill, B. Thilaganathan, John Townend, Edmund Juszczak, Neil Marlow, Andrew Shennan

Notice bibliographique

RevueHealth Technology Assessment · 2022
Typearticle
Langueen
DomaineMedicine
ThématiquePregnancy and preeclampsia studies
Établissements canadiensnon disponible
Organismes subventionnairesOxford University Hospitals NHS Foundation TrustDalhousie UniversityUniversity of OxfordHealth Technology Assessment ProgrammeImperial College LondonNational Institute for Health and Care ResearchUniversity of BristolDepartment of Health and Social CareInvention for InnovationUniversity Hospital Southampton NHS Foundation TrustPhilips
Mots-clésMedicineRandomized controlled trialGestationPhoenixObstetricsEclampsiaPreeclampsiaPregnancySurgery

Résumé

récupéré en direct d'OpenAlex

Background: weeks' gestation), the optimal delivery time is unclear because limitation of maternal-fetal disease progression needs to be balanced against infant complications. The aim of this trial was to determine whether or not planned earlier initiation of delivery reduces maternal adverse outcomes without substantial worsening of perinatal or infant outcomes, compared with expectant management, in women with late preterm pre-eclampsia. Methods: We undertook an individually randomised, triple non-masked controlled trial in 46 maternity units across England and Wales, with an embedded health economic evaluation, comparing planned delivery and expectant management (usual care) in women with late preterm pre-eclampsia. The co-primary maternal outcome was a maternal morbidity composite or recorded systolic blood pressure of ≥ 160 mmHg (superiority hypothesis). The co-primary short-term perinatal outcome was a composite of perinatal deaths or neonatal unit admission (non-inferiority hypothesis). Analyses were by intention to treat, with an additional per-protocol analysis for the perinatal outcome. The primary 2-year infant neurodevelopmental outcome was measured using the PARCA-R (Parent Report of Children's Abilities-Revised) composite score. The planned sample size of the trial was 900 women; the trial is now completed. We undertook two linked substudies. Results: = 0.147). Planned delivery was significantly cost-saving (-£2711, 95% confidence interval -£4840 to -£637) compared with expectant management. There were 9 serious adverse events in the planned delivery group and 12 in the expectant management group. Conclusion: In women with late preterm pre-eclampsia, planned delivery reduces short-term maternal morbidity compared with expectant management, with more neonatal unit admissions related to prematurity but no indicators of greater short-term neonatal morbidity (such as need for respiratory support). At 2-year follow-up, around 60% of parents reported follow-up scores. Average infant development was within the normal range for both groups; the small between-group mean difference in PARCA-R scores is unlikely to be clinically important. Planned delivery was significantly cost-saving to the health service. These findings should be discussed with women with late preterm pre-eclampsia to allow shared decision-making on timing of delivery. Limitations: Limitations of the trial include the challenges of finding a perinatal outcome that adequately represented the potential risks of both groups and a maternal outcome that reflects the multiorgan manifestations of pre-eclampsia. The incidences of maternal and perinatal primary outcomes were higher than anticipated on the basis of previous studies, but this did not limit interpretation of the analysis. The trial was limited by a higher loss to follow-up rate than expected, meaning that the extent and direction of bias in outcomes (between responders and non-responders) is uncertain. A longer follow-up period (e.g. up to 5 years) would have enabled us to provide further evidence on long-term infant outcomes, but this runs the risk of greater attrition and increased expense. Future work: We identified a number of further questions that could be prioritised through a formal scoping process, including uncertainties around disease-modifying interventions, prognostic factors, longer-term follow-up, the perspectives of women and their families, meta-analysis with other studies, effect of a similar intervention in other health-care settings, and clinical effectiveness and cost-effectiveness of other related policies around neonatal unit admission in late preterm birth. Trial registration: The trial was prospectively registered as ISRCTN01879376. Funding: Vol. 27, No. 28. See the NIHR Journals Library website for further project information.

Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.

Comment cette classification a été obtenuedéplier

Prédiction machine sur la base complète

Imitation des enseignants

Ni prévalence calibrée, ni vérité terrain. Validation humaine à venir. Le volet Gemma est une étiquette directe du modèle pour chaque travail de la base, lue sur la notice réduite au titre. Le volet Codex est un classifieur appris des 10 348 étiquettes directes de Codex et calibré sur les taux pondérés de l'échantillon; les champs sans appui suffisant ne portent aucun appel Codex. Le mode candidate est l'union des deux volets; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont pas des étiquettes humaines.

score de la tête « metaresearch » (Codex)0,005
score de la tête « metaresearch » (Gemma)0,010
Version: metacan-v3-hybrid-931329e0061cStatut de validation: machine_predicted_unvalidated
Catégories candidatesaucune
Catégories consensuellesaucune
DomaineSignal candidat: aucune · Signal consensuel: aucune
Devis d'étudeSignal candidat: Essai randomisé · Signal consensuel: Essai randomisé
GenreSignal candidat: Empirique · Signal consensuel: Empirique
Score de désaccord entre enseignants0,011
Score d'incertitude au seuil0,037

Scores du classifieur distillé par catégorie (deux têtes)

CatégorieCodexGemma
Métarecherche0,0050,010
Méta-épidémiologie (sens strict)0,0010,000
Méta-épidémiologie (sens large)0,0020,003
Bibliométrie0,0000,001
Études des sciences et des technologies0,0000,000
Communication savante0,0010,001
Science ouverte0,0010,001
Intégrité de la recherche0,0010,002
Charge utile insuffisante (le modèle a refusé de juger)0,0110,000

Scores machine (provisoires)

Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.

Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.

Tête enseignante Opus0,035
Tête enseignante GPT0,364
Écart entre enseignants0,329 · la distance entre les deux têtes enseignantes sur ce seul travail
Statut de validationscore_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découle

Classification

machine, non validée

Prédiction automatique; un appel candidat d’une seule source (Gemma direct ou Codex distillé), pas un consensus.

Les modèles n’ont appliqué aucune catégorie : rien dans la taxonomie ne correspondait à ce travail.
Devis d'étudeEssai randomisé
Domainenon disponible
GenreEmpirique

Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».

En bref

Citations4
Publié2022
Routes d'admission1
Résumé présentoui

Explorer davantage

Même revueHealth Technology AssessmentMême sujetPregnancy and preeclampsia studiesTravaux en français237 207